Penalties for Non-Registration of Clinical Trials

Introduction

Clinical trial registration is the process of recording a clinical study in a publicly accessible registry before enrolling its first participant. In India, the Clinical Trials Registry–India (CTRI) promotes transparency, accountability, and public access to information about clinical research. Registration helps prevent selective reporting, undisclosed changes to trial outcomes, and unnecessary duplication of experiments.

The Central Drugs Standard Control Organization (CDSCO) confirms that registration in CTRI is mandatory before the first participant is enrolled in a clinical trial covered by the applicable rules. This requirement also applies to relevant multinational trials conducted in India.

Final FAQ NDCT Rules 2019.docx

+1

Legal Provisions and Possible Consequences

New Drugs and Clinical Trials Rules, 2019: These rules govern clinical trials involving new drugs and investigational new drugs. Registration and other regulatory requirements must be followed alongside applicable permissions and ethical safeguards.

CDSCO

+1

Suspension or cancellation: Where non-registration accompanies a breach of trial-permission conditions or other regulatory requirements, authorities may consider appropriate action under the applicable rules. The precise consequence depends on the provision violated and the facts.

Institutional sanctions: Researchers may face disciplinary proceedings, academic sanctions, or ethics-committee action under applicable institutional policies. CTRI warns that retrospective registration, false declarations, or forged documents may result in reporting to authorities and freezing of a registrant’s account.

India (CTRI)

Important legal qualification: A 2025 study in Health Research Policy and Systems found that 46 of 381 examined regulatory trials—12%—had no matching CTRI record. The authors reported that, to their knowledge, no specific penalty for non-registration existed and no formal process confirmed that every permitted trial had been registered. Thus, there is no clearly established, universal standalone fine or prison term solely for failure to register a trial in CTRI; other violations may attract separate consequences.

Springer Nature Link

Important Case Laws

1. Swasthya Adhikar Manch, Indore v. Union of India, W.P. (C) No. 33 of 2012, Supreme Court of India

The Supreme Court examined concerns about malpractice, safety, and inadequate oversight in clinical trials. Its orders required stronger supervision and safeguards for participants, contributing to reforms in India’s clinical-trial regulatory framework. The case demonstrates the judiciary’s role in protecting research participants, although it did not prescribe a specific penalty solely for failure to register a trial.

SpotLaw

+1

2. Samira Kohli v. Dr. Prabha Manchanda, (2008) 2 SCC 1

The Supreme Court of India emphasised the importance of informed consent before medical procedures, subject to recognised exceptions. Although it was not a trial-registration case, its principles are relevant to clinical research: registration cannot replace informed consent, and compliance with registry requirements does not excuse violations of participants’ rights.

Conclusion

Clinical trial registration in India is an important regulatory and ethical requirement intended to promote transparency and protect participants. Non-registration may lead to regulatory scrutiny and institutional consequences, especially when combined with unauthorised trial conduct, false declarations, or other violations. However, the applicable legal provision must be identified before claiming that a particular fine or imprisonment term applies.